Non-Surgical Treatment of Colonic Diverticulitis (a Review)

Colonic diverticulitis poses an adverse medical and social problem for its prevalence, variety of clinical manifestations and complications and is becoming menacing as the people’s life expectancy reaches beyond 80 years. Many of the traditional principles no longer apply. This situation warrants an earlier diagnosis of colonic diverticulitis, its adequate treatment and prevention. The article presents a review of current literature on the conservative treatment of inflammatory colonic diverticulitis. The past 20 years have witnessed a noticeable increase to 20 % of hospitalisation rate with complicated diverticulitis and a higher associated financial burden. We discuss issues in the diagnosis and criteria for diverticulitis severity assessment with laboratory, biochemical data and radiation imaging (computer tomography, magnetic resonance imaging, ultrasound, colonoscopy). A critical overview is provided on anti-inflammatory and antibiotic drug usage in recurrence prevention and treatment of acute and recurrent diverticulitis, aside to recommendations in outpatient care. Despite a manifold of clinical studies and guidelines available, the adequate choice of drugs, dosages and duration of treatment remains an open challenge.

1. Rezapour M., Ali S., Stollman N. Diverticular disease: an update on pathogenesis and management. Gut Liver. 2018;12:125–32. DOI: 10.5009/gnl16552

2. Peery AF. Recent Advances in Diverticular Disease. Curr Gastroenterol Rep. 2016 Jul;18(7):37. DOI: 10.1007/s11894-016-0513-1

3. Kupcinskas J., Strate L.L., Bassotti G., Torti G., Herszènyi L., Malfertheiner P., et al. Pathogenesis of diverticulosis and diverticular disease. J Gastrointestin Liver Dis. 2019;28(suppl. 4):7–10. DOI: 10.15403/jgld-551

4. Peery A.F., Crockett S.D., Murphy C.C., Lund J.L., Dellon E.S., Williams J.L., et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology. 2019;156:254–72.e11. DOI: 10.1053/j.gastro.2018.08.063

5. Wheat C.L., Strate L.L. Trends in hospitalization for diverticulitis and diverticular bleeding in the United States from 2000 to 2010. Clin Gastroenterol Hepatol. 2016;14:96–103.e1. DOI: 10.1016/j.cgh.2015.03.030

6. Peery A.F., Crockett S.D., Barritt A.S., Dellon E.S., Eluri S., Gangarosa L.M., et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149:1731–41.e3. DOI: 10.1053/j.gastro.2015.08.045

7. Bollom A., Austrie J., Hirsch W., Nee j., Friedlander D., Ellingson K., et al. Emergency department burden of diverticulitis in the USA, 2006–2013. Dig Dis Sci. 2017;62:2694–703. DOI: 10.1007/s10620-017-4525-y

8. Masoomi H., Buchberg B., Nguyen B., Tung V., Stamos M.J., Mills S. Outcomes of laparoscopic versus open colectomy in elective surgery for diverticulitis. World J Surg. 2011;35:2143–8. DOI: 10.1007/s00268-011-1117-4

9. Jeger V., Pop R., Forudastan F., Barras J.P., Zuber M., Piso R.J. Is there a role for procalcitonin in diff erentiating uncomplicated and complicated diverticulitis in order to reduce antibiotic therapy? A prospective diagnostic cohort study. Swiss Med Wkly. 2017;147:w14555. DOI: 10.4414/smw.2017.14555

10. Hogan J., Sehgal R., Murphy D., O’Leary P., Coff ey J.C. Do infl ammatory indices play a role in distinguishing between uncomplicated and complicated diverticulitis? Dig Surg.2017;34:7–11. DOI: 10.1159/000447250

11. Kechagias A., Rautio T., Makela J. Th e early c-reactive protein trend does not have a role in monitoring acute diverticulitis progression. Chirurgia (Bucur). 2016;111(1):43–7. PMID: 26988538

12. Mäkelä J.T., Klintrup K., Takala H., Rautio T. Th e role of C-reactive protein in prediction of the severity of acute diverticulitis in an emergency unit. Scand J Gastroenterol. 2015;50(5):536–41. DOI: 10.3109/00365521.2014.999350

13. Bolkenstein H.E., van de Wall B.J., Consten E.C., van der Palen J., Broeders I.A, Draaisma W.A. Development and validation of a diagnostic prediction model distinguishing complicated from uncomplicated diverticulitis. Scand J Gastroenterol. 2018;53(10-11):1291–7. DOI: 10.1080/00365521.2018.1517188

14. Alshamari M., Norrman E., Geijer M., Jansson K., Geijer H. Diagnostic accuracy of low-dose CT compared with abdominal radiography in non-traumatic acute abdominal pain: prospective study and systematic review. Eur Radiol. 2016;26:1766–74. DOI: 10.1007/s00330-015-3984-9

15. Wasvary H., Turfah F., Kadro O., Beauregard W. Same hospitalization resection for acute diverticulitis. Am Surg. 1999;65:632–6. PMID: 10399971

16. Hall J.F., Roberts P.L., Ricciardi R., Read T., Scheirey C., Wald C, et al. Long-term follow-up aft er an initial episode of diverticulitis: what are the predictors of recurrence? Dis Colon Rectum. 2011;54(3):283–8. DOI: 10.1007/DCR.0b013e3182028576

17. Kameda T., Kawai F., Taniguchi N., Kobori Y. Usefulness of transabdominal ultrasonography in excluding adnexal disease. J Med Ultrason (2001). 2016;43(1):63–70. DOI: 10.1007/s10396-015-0666-9

18. Nielsen K., Richir M.C., Stolk T.T., van der Ploeg T., Moormann G.R.H.M., Wiarda B.M., et al. Th e limited role of ultrasound in the diagnostic process of colonic diverticulitis. World J Surg. 2014;38(7):1814–8. DOI: 10.1007/s00268-013-2423-9

19. Schreyer A.G., Layer G., German Society of Digestive and Metabolic Diseases (DGVS) as well as the German Society of General and Visceral Surgery (DGAV) in collaboration with the German Radiology Society (DRG). S2k guidlines for diverticular disease and diverticulitis: diagnosis, classifi cation, and therapy for the radiologist. Rofo. 2015;187(8):676–84. DOI: 10.1055/s-0034-1399526

20. Dirks K., Calabrese E., Dietrich C.F., Gilja O.H., Hausken T., Higginson A., et al. EFSUMB position paper: recommendations for gastrointestinal ultrasound (GIUS) in acute appendicitis and diverticulitis. Ultraschall Med. 2019;40(2):163–75. DOI: 10.1055/a-0824-6952

21. istä E., Hjern F., Blomqvist L., Von Heijne A., Abraham-Nordling M. Cancer and diverticulitis of the sigmoid colon. Diff erentiation with computed tomography versus magneticresonance imaging: preliminary experiences. Acta Radiol. 2013;54(3):237–41. DOI: 10.1258/ar.2012.120543

22. Daniels L., Unlu C., de Korte N., van Dieren S., Stockmann H.B., Vrouenraets B.C., et al. Randomized clinical trial of observational versus antibiotic treatment for a fi rst episode of CT-proven uncomplicated acute diverticulitis. Br J Surg. 2017;104(1):52–61. DOI: 10.1002/bjs.10309

23. Mege D., Yeo H. Meta-analyses of current strategies to treat uncomplicated diverticulitis. Dis Colon Rectum. 2019;62(3):371–8. DOI: 10.1097/DCR.0000000000001295

24. Isacson D., Smedh K., Nikberg M., Chabok A. Long-term follow-up of the AVOD randomized trial of antibiotic avoidance in uncomplicated diverticulitis. Br J Surg. 2019;106(11):1542–8. DOI: 10.1002/bjs.11239

25. van Dijk S.T., Daniels L., Unlu C., de Korte N., van Dieren S., Stockmann H.B., et al. Long-term eff ects of omitting antibiotics in uncomplicated acute diverticulitis. Am J Gastroenterol. 2018;113(7):1045–52. DOI: 10.1038/s41395-018-0030-y

26. Shabanzadeh D.M., Wille-Jørgensen P. Antibiotics for uncomplicated diverticulitis. Cochrane Database System Rev. 2012;(11):CD009092. DOI: 10.1002/14651858.CD009092.pub2.

27. Estrada Ferrer O., Ruiz Edo N., Hidalgo Grau L.A., Abadal Prades M., Del Bas Rubia M., Garcia Torralbo E.M., et al. Selective nonantibiotic treatment in sigmoid diverticulitis: is it time to change the traditional approach? Tech Coloproctol. 2016;20(5):309–15. DOI: 10.1007/s10151-016-1464-0

28. Emile S.H., Elfeki H., Sakr A., Shalaby M. Management of acute uncomplicated diverticulitis without antibiotics: a systematic review, meta-analysis, and meta-regression of predictors of treatment failure. Tech Coloproctol. 2018;22(7):499–509. DOI: 10.1007/s10151-018-1817-y

29. Bolkenstein H.E., Draaisma W.A., van de Wall B., Consten E., Broeders I. Treatment of acute uncomplicated diverticulitis without antibiotics: risk factors for treatment failure. Int J ColorectalDis. 2018;33(7):863–9. DOI: 10.1007/s00384-018-3055-1

30. Feingold D., Steele S.R., Lee S., Kaiser A., Boushey R., Buie W.D., et al. Practice parameters for the treatment of sigmoid diverticulitis. Dis Colon Rectum. 2014;57(3):284–94. DOI: 10.1097/DCR.0000000000000075

31. Schug-Pass C., Geers P., Hugel O., Lippert H., Kockerling F. Prospective randomized trial comparing short-term antibiotic therapy versus standard therapy for acute uncomplicated sigmoid diverticulitis. Int J Colorectal Dis. 2010;25(6):751–9. DOI: 10.1007/s00384-010-0899-4

32. Biondo S., Golda T., Kreisler E., Espin E., Vallribera F., Oteiza F., et al. Outpatient versus hospitalization management for uncomplicated diverticulitis: a prospective, multicenter randomized clinical trial (DIVER Trial). Ann Surg. 2014;259(1):38–44. DOI: 10.1097/SLA.0b013e3182965a11

33. Gregersen R., Mortensen L.Q., Burcharth J., Pommergaard H.C., Rosenberg J. Treatment of patients with acute colonic diverticulitis complicated by abscess formation: a systematic review. Int J Surg. 2016;35:201–8. DOI: 10.1016/j.ijsu.2016.10.006

34. Elagili F., Stocchi L., Ozuner G., Kiran R.P. Antibiotics alone instead of percutaneous drainage as initial treatment of large diverticular abscess. Tech Coloproctol. 2015;19(2):97–103. DOI: 10.1007/s10151-014-1250-9

35. Devaraj B., Liu W., Tatum J., Cologne K., Kaiser A.M. Medically treated diverticular abscess associated with high risk of recurrence and disease complications. Dis Colon Rectum. 2016;59(3):208–15. DOI: 10.1097/DCR.0000000000000533

36. Garfi nkle R., Kugler A., Pelsser V., Vasilevsky C.-A., Morin N., Gordon P., et al. Diverticular abscess managed with long-term defi nitive nonoperative intent is safe. Dis Colon Rectum. 2016;59(7):648–55. DOI: 10.1097/DCR.0000000000000624

37. Toorenvliet B.R., Swank H., Schoones J.W., Hamming J.F., Bemelman W.A. Laparoscopic peritoneal lavage for perforated colonic diverticulitis: a systematic review. Colorectal Dis. 2010;12(9):862–7. DOI: 10.1111/j.1463-1318.2009.02052.x

38. Strate L.L., Morris A.M. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology. 2019;156(5):1282–98.e1. DOI: 10.1053/j.gastro.2018.12.033

39. Schafmayer C., Harrison J.W., Buch S., Lange Ch., Reichert M.C., Hofer Ph., et al. Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms. Gut. 2019;68(5):854–65. DOI: 10.1136/gutjnl-2018-317619

40. Strate L.L., Keeley B.R., Cao Y., Wu K., Giovannucci E.L., Chan AT. Western dietary pattern increases, and prudent dietary pattern decreases, risk of incident diverticulitis in a prospective cohort study. Gastroenterology. 2017;152(5):1023–30.e2. DOI: 10.1053/j.gastro.2016.12.038

41. Liu P.H., Cao Y., Keeley B.R., Tam I., Wu K., Strate L.L., et al. Adherence to a healthy lifestyle is associated with a lower risk of diverticulitis among men. Am J Gastroenterol. 2017;112(12):1868–76. DOI: 10.1038/ajg.2017.398

42. Aune D., Sen A., Norat T., Riboli E. Dietary fi bre intake and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr. 2020;59(2):421–32. DOI: 10.1007/s00394-019-01967-w

43. Aune D., Sen A., Leitzmann M.F., Tonstad S., Norat T., Vatten LJ. Tobacco smoking and the risk of diverticular disease — a systematic review and meta-analysis of prospective studies. Colorectal Dis. 2017;19(7):621–33. DOI: 10.1111/codi.13748

44. Aune D., Sen A., Leitzmann M.F., Norat T., Tonstad S., Vatten L.J. Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies. Eur J Nutr. 2017;56(8):2423–38. DOI: 10.1007/s00394-017-1443-x

45. Picchio M., Elisei W., Brandimarte G., Di Mario F., Malfertheiner P., Scarpignato C., et al. Mesalazine for the treatment of symptomatic uncomplicated diverticular disease of the colon and for primary prevention of diverticulitis: a systematic review of randomized clinical trials. J Clin Gastroenterol. 2016;50(suppl 1):S64–9. DOI: 10.1097/MCG.0000000000000669

46. Picchio M., Elisei W., Tursi A. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials. J Gastrointestin Liver Dis. 2018;27(3):291–7. DOI: 10.15403/jgld.2014.1121.273.pic

47. Carter F., Alsayb M., Marshall J.K., Yuan Y. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis. Cochrane Database Syst Rev. 2017;10:CD009839. DOI: 10.1002/14651858.CD009839.pub2

48. Lanas A., Ponce J., Bignamini A., Mearin F. One year intermittent rifaximin plus fi bre supplementation vs. fi bre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis. 2013;45(2):104–9. DOI: 10.1016/j.dld.2012.09.006

49. Moniuszko A., Rydzewska G. Th e eff ect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study. Prz Gastroenterol. 2017;12(2):145–51. DOI: 10.5114/pg.2017.68167

50. Bianchi M., Festa V., Moretti A., Ciaco A., Mangone M., Tornatore V., et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Th er. 2011;33(8):902–10. DOI: 10.1111/j.1365-2036.2011.04606.x

51. Tursi A., Brandimarte G., Elisei W., Picchio M., Forti G., Pianese G., et al. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease–a double- blind, randomised, placebo-controlled study. Aliment Pharmacol Th er. 2013;38(7):741–51. DOI: 10.1111/apt.12463

52. Suhardja T.S., Norhadi S., Seah E.Z., Rodgers-Wilson S. Is early colonoscopy aft er CT-diagnosed diverticulitis still necessary? Int J Colorectal Dis. 2017;32(4):485–9. DOI: 10.1007/s00384-016-2749-5

53. Sallinen V., Mentula P., Leppдniemi A. Risk of colon cancer aft er computed tomography-diagnosed acute diverticulitis: is routine colonoscopy necessary? Surg Endosc. 2014;28(3):961–6. DOI: 10.1007/s00464-013-3257-0

54. Sharma P.V., Eglinton T., Hider P., Frizelle F. Systematic review and meta-analysis of the role of routine colonic evaluation aft er radiologically confi rmed acute diverticulitis. Ann Surg. 2014;259(2):263–72. DOI: 10.1097/SLA.0000000000000294

55. Meyer J., Orci L.A., Combescure C., et al. Risk of colorectal cancer in patients with acute diverticulitis: a systematic review and metaanalysis of observational studies. Clin Gastroenterol Hepatol. 2019;17(8):1448–56.e17. DOI: 10.1016/j.cgh.2018.07.031

56. Lahat A., Yanai H., Menachem Y., Avidan B., Bar-Meir S. Th e feasibility and risk of early colonoscopy in acute diverticulitis: a prospective controlled study. Endoscopy. 2007;39(6):521–4. DOI: 10.1055/s-2007-966399

57. Elmi A., Hedgire S.S., Pargaonkar V., Cao K., McDermott S., Harisinghani M. Is early colonoscopy benefi cial in patients with CT-diagnosed diverticulitis? AJR Am J Roentgenol. 2013;200(6):1269–74. DOI: 10.2214/AJR.12.9539

58. Ramphal W., Schreinemakers J.M., Seerden T.C., Crolla R.M., Rijken A.M., Gobardhan P.D. What is the risk of colorectal cancer aft er an episode of acute diverticulitis in conservatively treated patients? J Clin Gastroenterol. 2016;50(4):e35–9. DOI: 10.1097/MCG.0000000000000373

59. Walker A.S., Bingham J.R., Janssen K.M., et al. Colonoscopy aft er Hinchey I and II left -sided diverticulitis: utility or futility? Am J Surg. 2016;212(5):837–43. DOI: 10.1016/j.amjsurg.2016.02.012